News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NuSirt Biopharma Launches First Clinical Trial


8/20/2014 10:15:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NASHVILLE, Tenn.--(BUSINESS WIRE)--NuSirt Biopharma, Inc., is initiating a clinical trial with a goal of demonstrating whether the company’s patented technology may enhance the ability of a common Type 2 diabetes medication, metformin, to control blood sugar. The primary design of this Phase 2A trial is to test whether the combination of NuSirt technology and three different low doses of metformin can effectively control glucose levels when compared with full doses of metformin alone. In this trial, NuSirt’s technology employs a patented blend of leucine, an essential amino acid, coupled with an existing pharmaceutical compound.

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES